揭示TIMP1:结直肠癌中的一个多方面的生物标志物
Xiaode Qiu1,2, Guangqian Quan2, Wenquan Ou2
1Department of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Frontiers in genetics
|October 16, 2023
概括
这项研究确定了TIMP1作为结直肠癌 (CRC) 的关键生物标志物,将其表达与免疫细胞透,药物敏感性和铁亡联系起来. TIMP1为CRC提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 的发病因子和治疗点仍然不完全理解.
- 识别新的生物标志物对于有效的CRC诊断和治疗至关重要.
研究的目的:
- 使用生物信息学和实验方法探索和验证结直肠癌的生物标志物.
- 调查已识别的生物标志物作为治疗点的潜力.
主要方法:
- 从基因表达总 (GEO) 数据集中对差异表达基因 (DEG) 的分析.
- 使用癌症基因图谱 (TCGA) 和免疫组织化学 (IHC) 进行枢纽基因查和验证.
- 基因组丰富分析 (GSEA),用于免疫细胞透的CIBERSORT,药物敏感性分析 (DepMap) 和铁亡相关性分析.
主要成果:
- 确定了159个DEG和7个枢纽基因,TIMP1成为最重要的诊断和预后生物标志物.
- 在结直肠癌中通过IHC验证高TIMP1表达.
- 发现TIMP1表达与免疫细胞透 (巨细胞,中性粒细胞),免疫检查点 (CTLA-4,HAVCR2),药物敏感性和与铁死相关的基因 (GPX4,HSPA5) 相关联.
结论:
- TIMP1 作为结直肠癌的一个有价值的生物标志物.
- 在CRC中,TIMP1表达与瘤免疫微环境,药物敏感性和ferroptosis抑制有关.
相关概念视频
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


